Page last updated: 2024-11-05

todralazine and Lupus Erythematosus, Systemic

todralazine has been researched along with Lupus Erythematosus, Systemic in 2 studies

Todralazine: An antihypertensive agent with both central and peripheral action; it has some central nervous system depressant effects.

Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Drozdz, M2
Olczyk, K1
Kucharz, EJ1

Other Studies

2 other studies available for todralazine and Lupus Erythematosus, Systemic

ArticleYear
[Studies on metabolism of collagen in rats with experimentally induced collagen-like syndrome (author's transl)].
    Przeglad lekarski, 1980, Volume: 37, Issue:4

    Topics: Animals; Collagen; Hydralazine; Lupus Erythematosus, Systemic; Rats; Todralazine

1980
Influence of long-term treatment with hydrazinophthalazines on the activity of lysosomal exoglycosidases in rat tissues.
    Acta medica Hungarica, 1988, Volume: 45, Issue:2

    Topics: Animals; Antibodies, Anti-Idiotypic; Disease Models, Animal; Glycoside Hydrolases; Hydralazine; Hydr

1988